Angela Celetti
10PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 19, 2025
CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.Daniela Criscuolo, Francesco Merolla, Benedetta Pellegrino
|Nov 07, 2022
A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options.Daniela Criscuolo, Francesco Morra, Angela Celetti
|Aug 13, 2022
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.Francesco Morra, Francesco Merolla, Giovanna Damia
|Aug 07, 2021
Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress.Virginia Napolitano, Daniela Russo, Francesco Morra
|Dec 28, 2019
NSCLC Mutated Isoforms of CCDC6 Affect the Intracellular Distribution of the Wild Type Protein Promoting Cisplatinum Resistance and PARP Inhibitors Sensitivity in Lung Cancer Cells.Aniello Cerrato, Francesco Morra, Imma Di Domenico
|Oct 20, 2019
CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC.Francesco Morra, Francesco Merolla, Ida Picardi
Pageof 2
Frequent Collaborators
3 joint publications
Francesco Merolla
3 joint publications
Francesco Morra
2 joint publications
Daniela Criscuolo
1 joint publications
Gennaro Ilardi
1 joint publications
Luca Palazzo
1 joint publications
Virginia Napolitano
1 joint publications
Francesco Martino
1 joint publications
Massimo Mascolo
1 joint publications
Stefania Staibano
1 joint publications
Benedetta Pellegrino
